Bolt Biotherapeutics, Inc. (BOLT) has a consensus analyst rating of Hold, based on 8 analysts covering the stock. Of those, 3 recommend buying, 5 recommend holding, and 0 recommend selling.
The analyst consensus price target for BOLT is $7.00, representing a +50.2% upside from the current price of $4.66. Price targets range from a low of $7.00 to a high of $7.00.
